Skip to content

Clinical trials

Phase 1 Uterine Cervical Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20171
20191
20205
20213
20223
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting6
Terminated5
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Seagen Inc.3
AstraZeneca2
AbbVie1
Alterome Therapeutics, Inc.1
Arcus Biosciences, Inc.1
Atavistik Bio, Inc1
EMD Serono Research & Development Institute, Inc.1
Exelixis1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms22
Carcinoma, Non-Small-Cell Lung16
Ovarian Neoplasms13
Triple Negative Breast Neoplasms12
Endometrial Neoplasms11
Stomach Neoplasms10
Esophageal Neoplasms9
Squamous Cell Carcinoma of Head and Neck9
Melanoma8
Carcinoma, Renal Cell6

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.